The treatment of Autism & Hay Fever with vitamins

Autism and Hay Fever: Mitamins custom make quality formulas for the treatment of Autism & Hay Fever with vitamins. A Autism & Hay Fever formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Autism and Hay Fever

  • Amount Per Serving
    % DV
    Vitamin C
    100
    mg
    167%
    Vitamin E
    100
    IU
    333%
    Niacin
    25
    mg
    125%
    Vitamin B6
    25
    mg
    1250%
    Pantothenic Acid
    25
    mg
    250%
    Calcium
    50
    mg
    5%
    Magnesium
    50
    mg
    13%
    Zinc
    10
    mg
    67%
    Choline Bitartrate
    25
    mg
    *
  • Amount Per Serving
    % DV
    CoQ-10
    20
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    Grape Seed Extract
    50
    mg
    *
    Licorice Extract
    100
    mg
    *
    Quercetin
    100
    mg
    *
    L-Glutamine
    100
    mg
    *
    L-Tyrosine
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Autism and Hay Fever Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Tissue-Growth Gene Tied to Scleroderma (HealthDay)
New research suggests a gene governing the growth of connective tissue is key to scleroderma, an autoimmune disease in which the body builds up thick layers of scar tissue in the skin and around internal organs.
Patient Enrollment On Target In National Institutes Of Health Phase III Parkinson's Disease Trial
Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today that the Phase III efficacy trial of the Company's lead Parkinson's disease drug candidate, PD-02, has enrolled 288 patients in the first three months.
This information concerning the support of Autism and Hay Fever treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments